Minerva anestesiologica
-
Minerva anestesiologica · Aug 2019
LetterCarbon monoxide intoxication: prehospital diagnosis and direct transfer to the hyperbaric chamber.
Abstract
-
Minerva anestesiologica · Aug 2019
ReviewJoint consensus on anesthesia in urologic and gynecologic robotic surgery: specific issues in management from a task force of the SIAARTI, SIGO, and SIU.
Proper management of patients undergoing robotic-assisted urologic and gynecologic surgery must consider a series of peculiarities in the procedures for anesthesiology, critical care medicine, respiratory care, and pain management. Although the indications for robotic-assisted urogynecologic surgeries have increased in recent years, specific guidance documents are still lacking. ⋯ This consensus document provides guidance for the management of urologic and gynecologic patients scheduled for robotic-assisted surgery. Moreover, the identified unmet needs highlight the requirement for further prospective randomized studies.
-
Minerva anestesiologica · Aug 2019
An in-vitro study to evaluate high-volume low-pressure endotracheal tube cuff deflation dynamics.
High-volume low-pressure (HVLP) endotracheal tube (ETT) cuffs for critically ill patients often deflate during the course of mechanical ventilation. We performed an in-vitro study to comprehensively assess HVLP cuff deflation dynamics and potential preventive measures. ⋯ In controlled in-vitro settings, ETT cuffs consistently deflate over time, and the cuff pilot balloon valve plays a central role in this occurrence. Deflation rate decreases when cuffs are inflated within a plastic artificial tracheal model and mechanical ventilation is activated.
-
Minerva anestesiologica · Aug 2019
Comparative StudyComparison of the incidence of perioperative cardiovascular risk events among patients with and without a history of neoadjuvant chemotherapy.
Chemotherapy predisposes individuals to increased risk for future cardiac events. ⋯ Patients who underwent neoadjuvant chemotherapy prior to radical mastectomy were more prone to cardiovascular risk events than those without chemotherapy history.